Once-daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s745. https://doi.org/10.25251/32bs1796